Live Breaking News & Updates on Pharmacological sciences

Stay updated with breaking news from Pharmacological sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Researchers develop AI model to better predic

Data scientists at the Icahn School of Medicine at Mount Sinai in New York and colleagues have created an artificial intelligence model that may more accurately predict which existing medicines, not currently classified as harmful, may in fact lead to congenital disabilities. The model, or “knowledge graph,” described in the July 17 issue of the Nature journal Communications Medicine, also has the potential to predict the involvement of pre-clinical compounds that may harm the developing fetus. The study is the first known of its kind to use knowledge graphs to integrate various data types to investigate the causes of congenital disabilities.

New-york , United-states , Morningside , Pennsylvania , New-zealand , The-mount , New-zealand-general- , Philadelphia , Nassau , New-providence , Bahamas , The

Researchers develop AI model to better predict which drugs may cause birth defects

Researchers develop AI model to better predict which drugs may cause birth defects
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United-states , New-york , Avi-maayan , John-erol-evangelista , Pharmacological-sciences , Mount-sinai-center , Drug-administration , Us-environmental-protection-agency , Communications-medicine , Icahn-school-of-medicine-at-mount-sinai , Icahn-school , Mount-sinai

Researchers Develop AI Model to Better Predict Which Drugs May Cause Birth Defects

New York, NY (PRWEB) July 17, 2023 -- New York, NY (July 17, 2023)—Data scientists at the Icahn School of Medicine at Mount Sinai in New York and colleagues

United-states , New-york , Avi-maayan , Communications-medicine , Common-fund , Pharmacological-sciences , Icahn-school-of-medicine-at-mount-sinai , Mount-sinai-center , Icahn-school , Mount-sinai , Avi-ma-ayan , Icahn-mount-sinai

Biosimilars Increased Utilization, Price Reduction in European Markets

The use of infliximab, adalimumab and etanercept following biosimilar entry increased by 88.9%, 22.4%, and 14.6%, respectively.

Serbia , Leuven , Region-flamande , Belgium , Switzerland , Norway , United-kingdom , Pharmacological-sciences , European-union-member-states , Linkedin , Elif-car

24 Benefits of CBD Oil: 2023 Research Backed

With FDA approving epidiolex, a drug derived from cannabis, researchers have made it their business to try and discover the benefits of CBD oil.

United-kingdom , United-states , Japan , Laos , Lao , British , Japanese , American , Pankaj-bansal , Ishwarlal-jialal , Amandeep-goyal , Stampanoni-bassi

Omega-3 deficiency could raise risk of heart disease - signs to spot

One study of more than 8,000 people found that supplementing the fat into their diets helped reduce the number of heart attacks, strokes and death.

United-states , American , Poobashni-govender , Pharmacological-sciences , American-heart-association , Express , Rainbow-labs , Getty-images , European-review ,

Discovering the action mechanism of the most widely used type 2 diabetes drug

Discovering the action mechanism of the most widely used type 2 diabetes drug
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Barcelona , Comunidad-autonoma-de-cataluna , Spain , Emma-barroso , Institute-of-biomedicine , Metabolic-diseases-research-group , Research-institute , Metabolic-diseases-networking-biomedical-research-centre , Trends-in-pharmacological-sciences , Food-sciences-of-the-university-barcelona , Pharmacological-sciences , Food-sciences

Machine learning model improves mortality risk prediction in cardiac surgery

A machine learning-based model appeared to improve prediction of mortality risk for patients undergoing cardiac surgery compared with population-derived models, researchers reported.“The standard-of-care risk models used today are limited by their applicability to specific types of surgeries, leaving out significant numbers of patients undergoing complex or combination procedures for which

Gaurav-pandey , Ravi-iyengar , Icahn-school-of-medicine-at-mount-sinai , Lewis-rosenstiel-professor-of-pharmacological-sciences , Mount-sinai-institute-for-systems-biomedicine , Society-of-thoracic-surgeons , Lewis-rosenstiel-professor , Pharmacological-sciences , Icahn-school , Mount-sinai , Mount-sinai-institute , Systems-biomedicine